Abstract
Brain imaging is one of the valuable applications of the hybrid PET/MRI given the anatomical and physiological complexity of the brain and the subtlety of the neurological changes that accompany many of the neurodegenerative, epileptic, and oncological diseases. The limited resolution of CT in imaging brain makes the MRI the ideal modality for neuroimaging. This resulted in growing interest in the medical, physics, and pharmaceutical communities to develop novel radiopharmaceuticals and apply new MRI sequences for early diagnosis, predicting the behavior and having a better insight of the neurological disorders. This chapter provides a concise overview of the combined PET/MRI clinical uses in neuroimaging of patients with neurodegenerative, epileptic and brain neoplastic diseases. It also compares its advantages and disadvantages to those of other available imaging modalities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fraioli F, Punwani S. Clinical and research applications of simultaneous positron emission tomography and MRI. Br J Radiol. 2014;87(1033):20130464.
Kalemis A, Delattre BMA, Heinzer S. Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer’s perspective. Magn Reson Mater Phys Biol Med. 2013;26(1):5–23.
Tudisca C, Nasoodi A, Fraioli F. PET-MRI. Nucl Med Commun. 2015;36(7):666–78.
Schwenzer NF, et al. Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients—current state of image quality. Eur J Radiol. 2012;81(11):3472–8.
Hirata Y, et al. Voxel-based morphometry to discriminate early Alzheimer’s disease from controls. Neurosci Lett. 2005;382(3):269–74.
Guo X, et al. Voxel-based assessment of gray and white matter volumes in Alzheimer’s disease. Neurosci Lett. 2010;468(2):146–50.
Goubran M, et al. Assessment of PET & ASL metabolism in the hippocampal subfields of MCI and AD using simultaneous PET-MR. EJNMMI Phys. 2015;2(Suppl 1):A73.
Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. DTI analyses and clinical applications in Alzheimer’s disease. J Alzheimers Dis. 2011;26(Suppl 3):287–96.
Prasad G, Nir TM, Toga AW, Thompson PM. Tractography density and network measures in Alzheimer’s disease. In: 2013 IEEE 10th International Symposium on Biomedical Imaging, vol. 2013; 2013. p. 692–5.
Heiss W-D, Raab P, Lanfermann H. Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med. 2011;52(10):1585–600.
Rees JH. Diagnosis and treatment in neuro-oncology: an oncological perspective. Br J Radiol. 2011;84(Spec Iss 2):S82–9.
Knopp EA, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology. 1999;211(3):791–8.
Scott JN, Brasher PMA, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology. 2002;59(6):947–9.
Bisdas S, et al. Metabolic mapping of gliomas using hybrid MR-PET imaging. Investig Radiol. 2013;48(5):295–301.
Bisdas S, lá Fougere C, Ernemann U. Hybrid MR-PET in neuroimaging. Clin Neuroradiol. 2015;25:275–81.
Halac G, et al. Compatibility of MRI and FDG-PET findings with histopathological results in patients with focal cortical dysplasia. Seizure. 2017;45:80–6.
Shin HW, et al. Initial experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy. Seizure. 2015;31:1–4.
Ward BP. Arab Health: is PET/MRI really worth the extra cost? AuntMinnie Europe; 2013. p. 28–29.
Bailey DL, et al. Combined PET/MR: the real work has just started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany. Mol Imaging Biol. 2015;17(3):297–312.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fraioli, F., Almansory, K.O. (2019). Clinical Applications of PET/MRI in Brain Imaging. In: Fraioli, F. (eds) PET/CT in Brain Disorders. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-030-01523-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-01523-7_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01522-0
Online ISBN: 978-3-030-01523-7
eBook Packages: MedicineMedicine (R0)